DC Capital Partners specializes in control equity investments in middle market companies serving the U.S. federal government. The firm focuses on sectors including infrastructure, defense, aerospace, and outsourced government services. Their investments target companies providing innovative solutions to federal agencies.

The firm's portfolio includes Helios Health and Werewolf Therapeutics, demonstrating their interest in healthcare and biotechnology. DC Capital Partners aims to add value to portfolio companies by leveraging their expertise in federal contracting and their network within government sectors. Their investment approach emphasizes companies with differentiated services and strong growth potential.